Principles of bioactive lipid signalling: lessons from sphingolipids
Top Cited Papers
- 1 February 2008
- journal article
- review article
- Published by Springer Nature in Nature Reviews Molecular Cell Biology
- Vol. 9 (2), 139-150
- https://doi.org/10.1038/nrm2329
Abstract
The sphingolipids constitute an important class of bioactive lipids, including ceramide and sphingosine-1-phosphate (S1P). Ceramide can be considered to function as a hub in sphingolipid metabolism, and it mediates or regulates antiproliferative responses such as growth inhibition, apoptosis, differentiation and senescence, whereas S1P is a key regulator of cell motility and proliferation. The study of bioactive lipids in general and sphingolipids in particular presents several hurdles to molecular cell biologists. These include the hydrophobicity and biophysical properties of these molecules, the metabolic interconnections of the active metabolites, and the predominantly hydrophobic nature of the enzymes that regulate their metabolism. Enzymes of sphingolipid metabolism function as an interconnected network that regulates the levels and interconversions of the bioactive sphingolipids. Many of these enzymes, such as sphingomyelinases, sphingosine kinases and ceramide synthases, serve to couple the action of extra- and intracellular agonists to downstream effectors. Ceramide can be formed from the de novo pathway or following activation of the sphingomyelinase pathway, in which it functions in metabolic regulation and stress responses. Ceramide action is governed by the specific pathways that regulate its formation, their subcellular localization and their specific mechanisms of regulation. S1P is a product of sphingosine kinases, and acts predominantly on a family of G protein-coupled receptors that, in turn, mediate its action on cell growth, migration, transcription and signal transduction. The cellular actions of ceramide, S1P and other bioactive sphingolipids are increasingly thought to be crucial for the study of angiogenesis, inflammation, immune responses, diabetes, ageing, cancer biology and degenerative diseases.Keywords
This publication has 121 references indexed in Scilit:
- Neutral Sphingomyelinase (SMPD3) Deficiency Causes a Novel Form of Chondrodysplasia and Dwarfism That Is Rescued by Col2A1-Driven smpd3 Transgene ExpressionThe American Journal of Pathology, 2007
- Regulation of secretory transport by protein kinase D–mediated phosphorylation of the ceramide transfer proteinThe Journal of cell biology, 2007
- Involvement of Dihydroceramide Desaturase in Cell Cycle Progression in Human Neuroblastoma CellsJournal of Biological Chemistry, 2007
- Analysis of membrane topology of neutral sphingomyelinase 2FEBS Letters, 2007
- Role of ABCC1 in export of sphingosine-1-phosphate from mast cellsProceedings of the National Academy of Sciences, 2006
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005
- Amyloid‐β peptide enhances tumor necrosis factor‐α‐induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytesJournal of Neurochemistry, 2005
- BcR-induced Apoptosis Involves Differential Regulation of C16 and C24-Ceramide Formation and Sphingolipid-dependent Activation of the ProteasomeJournal of Biological Chemistry, 2003
- Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruptionBiochemical Society Transactions, 2001
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995